SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 39 filers reported holding SCPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $625,898 | +9.2% | 87,907 | +56.3% | 0.02% | +4.8% |
| Q2 2023 | $573,208 | -6.4% | 56,252 | -16.7% | 0.02% | -16.0% |
| Q1 2023 | $612,243 | -51.8% | 67,502 | -61.9% | 0.02% | -59.7% |
| Q4 2022 | $1,269,728 | +284.8% | 177,089 | +249.8% | 0.06% | +287.5% |
| Q3 2022 | $330,000 | -13.8% | 50,625 | -25.0% | 0.02% | -5.9% |
| Q1 2022 | $383,000 | -79.4% | 67,500 | -81.8% | 0.02% | -83.3% |
| Q4 2021 | $1,858,000 | -64.7% | 370,091 | -53.3% | 0.10% | -61.4% |
| Q3 2021 | $5,270,000 | +19.6% | 792,421 | +9.9% | 0.26% | +54.4% |
| Q2 2021 | $4,405,000 | +233.7% | 720,877 | +263.3% | 0.17% | +307.1% |
| Q1 2021 | $1,320,000 | – | 198,426 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,247,005 | $10,358,000 | 0.56% |
| Orbimed Advisors | 3,409,865 | $10,877,000 | 0.17% |
| Eversept Partners, LP | 174,297 | $556,007 | 0.16% |
| Alambic Investment Management, L.P. | 59,847 | $191,000 | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61,500 | $196,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 36,921 | $118,000 | 0.00% |
| Paloma Partners Management Co | 30,000 | $96,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,211 | $10,000 | 0.00% |
| SG Americas Securities, LLC | 12,877 | $41,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 967 | $3,000 | 0.00% |